001     281355
005     20251008102405.0
024 7 _ |a 10.1111/jsr.70109
|2 doi
024 7 _ |a pmid:40461179
|2 pmid
024 7 _ |a pmc:PMC12426715
|2 pmc
024 7 _ |a 0962-1105
|2 ISSN
024 7 _ |a 1365-2869
|2 ISSN
037 _ _ |a DZNE-2025-01102
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Cesari, Matteo
|0 0000-0001-6554-1033
|b 0
245 _ _ |a Isolated REM Sleep Behaviour Disorder-Is Screening Possible?
260 _ _ |a Oxford [u.a.]
|c 2025
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1759826113_17321
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia characterised by the loss of muscle atonia during REM sleep and dream-enacting behaviours. In its isolated form (iRBD) it is widely recognised as an early stage of alpha-synucleinopathies. Early identification of patients with iRBD allows for timely interventions, risk mitigation and potential inclusion in clinical trials aimed at disease modification. Effective screening tools, including questionnaires, automatic analyses of video-polysomnography, actigraphy, nearables and biological markers, can facilitate diagnosis and monitoring. Incorporating routine screening into clinical practice may enhance early detection and improve long-term patient outcomes. This manuscript presents the latest developments in screening tools for the identification of patients with iRBD and discusses their advantages and drawbacks, highlighting paths for future research and applications.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a RBD
|2 Other
650 _ 7 |a iRBD
|2 Other
650 _ 7 |a prodromal alpha‐synucleinopathy
|2 Other
650 _ 7 |a screening tool
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a REM Sleep Behavior Disorder: diagnosis
|2 MeSH
650 _ 2 |a Polysomnography
|2 MeSH
650 _ 2 |a Actigraphy
|2 MeSH
650 _ 2 |a Surveys and Questionnaires
|2 MeSH
650 _ 2 |a Mass Screening: methods
|2 MeSH
700 1 _ |a Brink-Kjaer, Andreas
|b 1
700 1 _ |a During, Emmanuel
|b 2
700 1 _ |a Ganglberger, Wolfgang
|0 0000-0002-6029-2450
|b 3
700 1 _ |a Gnarra, Oriella
|b 4
700 1 _ |a Huang, Bei
|b 5
700 1 _ |a Sommerauer, Michael
|0 P:(DE-2719)9003277
|b 6
|u dzne
700 1 _ |a Ratti, Pietro Luca
|b 7
700 1 _ |a Rechichi, Irene
|0 0000-0002-9420-4922
|b 8
700 1 _ |a Wing, Yun Kwok
|0 0000-0002-5745-5474
|b 9
700 1 _ |a Stefani, Ambra
|0 0000-0003-4259-8824
|b 10
773 _ _ |a 10.1111/jsr.70109
|g Vol. 34, no. 5, p. e70109
|0 PERI:(DE-600)2007459-1
|n 5
|p e70109
|t Journal of sleep research
|v 34
|y 2025
|x 0962-1105
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/281355/files/DZNE-2025-01102.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/281355/files/DZNE-2025-01102.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:281355
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9003277
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a Creative Commons Attribution CC BY 3.0
|0 LIC:(DE-HGF)CCBY3
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J SLEEP RES : 2022
|d 2024-12-09
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-09
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-09
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-09
920 1 _ |0 I:(DE-2719)1013020
|k AG Petzold
|l Vascular Neurology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013020
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21